Gregory T. Schiffman
Independent DirectorMr. Gregory T. Schiffman, also known as Greg, MBA, CPA serves as Director at BioEclipse Therapeutics, Inc. since August 01, 2016 and serves as its Chairman since 2025. Mr. Schiffman serves as an Independent Non-Executive Director at Mirror Biologics Inc., since August 2022. He served as Chief Financial Officer at Absci Corporation since April 01, 2020 until August 31, 2023. He served as the Chief Financial Officer of Lion Biotechnologies, Inc. from October 03, 2016 to June 22, 2017 and served as its Secretary until June 22, 2017. He serves on the boards of directors of BioEclipse, a private company. Mr. Schiffman served as the Chief Financial Officer and Executive Vice President of Finance of StemCells Inc. since January 1, 2014 until September 2016. Mr. Schiffman was responsible for all aspects of the StemCells' financing activities, financial reporting and controls, corporate communications and investor relations. Prior to StemCells, he served as the Chief Financial Officer of Dendreon Corporation from December 2006 to August 2013 and Executive Vice President from December 2006 to December 31, 2013. He had primary responsibility for capital raising, financial reporting and controls, information technology and investor relations. Mr. Schiffman served as Treasurer of Dendreon Corp. from December 14, 2006 to December 31, 2013 and served as its Executive Vice President from December 2010 to December 31, 2013. He served as Chief Financial Officer of Dendreon Corp. from December 14, 2006 to August 9, 2013. He served as Senior Vice President of Dendreon Corp., from December 14, 2006 to December 2010. Mr. Schiffman served as the Chief Financial Officer of Affymetrix Inc., from August 2001 to December 14, 2006 and also served as its Executive Vice President from February 2005 to December 14, 2006. He served as Senior Vice President of Affymetrix Inc., since October 2002. Mr. Schiffman joined Affymetrix in 2001. Mr. Schiffman served as Vice President of Finance for Affymetrix Inc. from March 2001 to August 2001 and Vice President since August 2001. Prior to Affymetrix, Mr. Schiffman served as Vice President and Controller of Applied Biosystems, Inc. since October 1998. Before entering the healthcare field, Mr. Schiffman held roles of increasing responsibility within Hewlett Packard, where he served as controller of its European P.C. manufacturing and distribution operations in Grenoble, France and as manufacturing manager and controller of its Netmetrix Division. Mr. Schiffman has been Independent Director of Nanomix Corporation since November 29, 2005. He serves as a Director of Fabric.AI, Inc. (formerly known as StableX Technologies, Inc.) (formerly known as Ayro, Inc.) since February 2018. He was an Independent Director of DropCar, Inc. since January 30, 2018 until May 2020. He was Chief Financial Officer of Iovance Biotherapeutics, Inc. from October 3, 2016 to June 22, 2017 and was its Corporate Secretary until June 22, 2017. He had been a Director of Xenogen Corporation since January 13, 2005 until July 2006. Mr. Schiffman has served as the Chief Financial Officer of privately-held AbSci, Limited Liability Company since April 01, 2020. He previously served as the Chief Financial Officer of Vineti, Incorporated from October 2017 to April 2018. He served as a Director of Vnus Medical Technologies Inc. since April 7, 2006 until July 2009. He served as a Director of Entelos, Inc. since February 12, 2007. He served as a Director of IMPAC Medical Systems, Inc., since February 2003 until April 2005. He served as Director at Nanomix since Janary 11, 2005 until September 01,2020.He is a CPA in Illinois. Mr. Schiffman holds a Master's in Business Administration from the J.L. Kellogg School of Management, Northwestern University and a Bachelor of Science degree in Accounting from DePaul University.
Positions
- Company NameFabric.AI, Inc.Stock CodeFABCPositionIndependent DirectorColleagues
- JNJoshua N. SilvermanChief Executive Officer & Executive Chairman
- JWJoseph W. RamelliChief Financial Officer
- GVGilbert VillarrealPresident of AYRO's Operating Company, Inc.
- JDJoseph DelahoussayeVice President of Investor Relations
- WMWilliam MaffucciHead of Development
- ZJZvi JosephIndependent Director
- SGSebastian GiordanoIndependent Director
- WRWayne R. WalkerIndependent Director
